How should intertrigo of the groin be managed in an obese female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Intertrigo in the Groin Area of an Obese Female

For groin intertrigo in an obese female, keep the area dry, apply topical antifungal therapy (clotrimazole, miconazole, or nystatin), and consider moisture-wicking antimicrobial fabric for faster symptom resolution.

Immediate Treatment Approach

The management follows a stepwise algorithm:

1. Moisture Control (Foundation of Treatment)

  • Keep the infected area dry - this is the single most important intervention 1
  • Apply moisture-wicking fabric with antimicrobial silver between skin folds, which achieves symptom resolution in 6 days versus 11 days with traditional treatment (p < 0.001) 2
  • Use absorptive powders (cornstarch) or barrier creams to minimize moisture and friction 3

2. Topical Antifungal Therapy

Since candidal superinfection is common in intertriginous areas, especially in obese and diabetic patients 1:

  • Apply topical azoles (clotrimazole or miconazole) or nystatin to the groin area 1
  • These are effective for candidal skin infections that typically occur as intertrigo in skin folds 1
  • Continue treatment until clinical resolution, typically 7-14 days 4

3. Clothing and Hygiene Modifications

  • Wear light, nonconstricting, absorbent clothing; avoid wool and synthetic fibers 3
  • Shower after physical activity and dry intertriginous areas thoroughly 3
  • Maintain structured skin care routine with regular cleansing and drying 5

Risk Factor Management

The groin area is affected in 9.6% of obese patients with intertrigo, with higher prevalence in females (12.3%), particularly those over 65 years with higher BMI 2. Address these predisposing factors:

  • Weight reduction - this is the first and key step of management 4
  • Screen for and manage diabetes mellitus, as it facilitates both occurrence and recurrence 4
  • Evaluate for immunosuppressive conditions if recurrent or treatment-resistant 4

When to Escalate Treatment

If the condition is treatment-resistant or recurrent:

  • Perform laboratory studies to confirm candidal infection and establish differential diagnosis 4
  • Consider systemic antifungal therapy (fluconazole 100 mg/day for 7-14 days) if topical therapy fails 1
  • Treat any intestinal colonization or periorificial infections that may serve as reservoirs 4

Common Pitfalls to Avoid

  • Don't rely solely on barrier products without addressing moisture control - keeping the area dry is more important than any topical agent 1
  • Don't overlook secondary bacterial infection - treat with appropriate antiseptics or antibiotics if present 3
  • Don't ignore predisposing factors - recurrence is common without addressing obesity, diabetes, and moisture accumulation 4

Evidence Quality Note

While the 2004 guideline provides the framework for antifungal selection 1, the most recent high-quality evidence from 2025 demonstrates that moisture-wicking antimicrobial fabric significantly accelerates symptom resolution compared to traditional treatment alone 2. This represents an important adjunctive therapy that should be considered alongside standard topical antifungals for optimal outcomes in obese patients.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.